Cystic fibrosis and insulin therapy: a reality check
- PMID: 30964946
- DOI: 10.1111/dme.13959
Cystic fibrosis and insulin therapy: a reality check
Comment in
-
To treat or not to treat: dysglycaemia in cystic fibrosis.Diabet Med. 2019 Nov;36(11):1365-1366. doi: 10.1111/dme.14112. Diabet Med. 2019. PMID: 31429490 No abstract available.
References
-
- Dobson L, Sheldon CD, Hattersley AT. Understanding cystic fibrosis-related diabetes: best thought of as insulin deficiency? J R Soc Med 2004; 97(Suppl 44): 26-35.
-
- Lanng S, Thorsteinnsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-687.
-
- Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162: 891-895.
-
- Tofe S, Moreno JC, Maiz L, Alonso M, Escobar H, Barrio R. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol 2005; 152: 241-247.
-
- Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL et al. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2007; 6: 101-109.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
